You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 19, 2024

FLUOCINONIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Fluocinonide, and when can generic versions of Fluocinonide launch?

Fluocinonide is a drug marketed by Amneal, Cosette, Encube, Fougera Pharms Inc, Glenmark Generics, Padagis Israel, Pai Holdings Pharm, Perrigo New York, Taro, Teva, Zydus Lifesciences, Alvogen, Padagis Us, Chartwell Rx, Fougera Pharms, Xiromed, Encube Ethicals, Macleods Pharms Ltd, Novel Labs Inc, Teva Pharms, Zydus Pharms, and Glenmark Pharms Ltd. and is included in forty-four NDAs.

The generic ingredient in FLUOCINONIDE is fluocinolone acetonide. There are twelve drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the fluocinolone acetonide profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Fluocinonide

A generic version of FLUOCINONIDE was approved as fluocinolone acetonide by TARO on April 27th, 1982.

  Try a Trial

Drug patent expirations by year for FLUOCINONIDE
Drug Prices for FLUOCINONIDE

See drug prices for FLUOCINONIDE

Drug Sales Revenue Trends for FLUOCINONIDE

See drug sales revenues for FLUOCINONIDE

Recent Clinical Trials for FLUOCINONIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Valeant Pharmaceuticals International, Inc.N/A
Rochester Skin Lymphoma Medical Group, PLLCN/A
Rochester General HospitalN/A

See all FLUOCINONIDE clinical trials

Pharmacology for FLUOCINONIDE
Medical Subject Heading (MeSH) Categories for FLUOCINONIDE
Paragraph IV (Patent) Challenges for FLUOCINONIDE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
VANOS Cream fluocinonide 0.1% 021758 1 2008-01-31

US Patents and Regulatory Information for FLUOCINONIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cosette FLUOCINONIDE EMULSIFIED BASE fluocinonide CREAM;TOPICAL 074204-001 Jun 13, 1995 AB2 RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Novel Labs Inc FLUOCINONIDE fluocinonide SOLUTION;TOPICAL 206003-001 Jul 21, 2017 AT RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Cosette FLUOCINONIDE fluocinonide SOLUTION;TOPICAL 071535-001 Dec 2, 1988 AT RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Pai Holdings Pharm FLUOCINONIDE fluocinonide SOLUTION;TOPICAL 207554-001 Mar 18, 2019 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Encube Ethicals FLUOCINONIDE fluocinonide SOLUTION;TOPICAL 209699-001 Nov 29, 2018 AT RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Amneal FLUOCINONIDE fluocinonide CREAM;TOPICAL 210554-001 Aug 21, 2018 AB1 RX No Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.